Graft-versus-host disease research shows promise | Dana-Farber Cancer Institute
3,378 views · Published 29 November 2011 · 3:07 · Indexed 1 November 2026
Channel: Dana-Farber Cancer Institute · 2011 · Education
John Koreth, MBBS, DPhil, discusses the results of a clinical trial to treat patients with graft-versus-host disease (GVHD), which can affect the immune system after transplant. He notes that the results may also have implications for other immune system-related diseases such as lupus and multiple sclerosis.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute